Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
RARE —
ULTRAGENYX PHARMACEUTICAL IN
CUSIP: 90400D108 · Held by 2 superinvestors · Combined value: $69,639,975
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Ken Griffin | 0.0% | $61,219,675 | 2,661,725 | ADD | +2,070,172 |
| 2 | Jim Simons | 0.0% | $8,420,300 | 366,100 | ADD | +344,200 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +344,200 | +1571.7% |
| Ken Griffin | ADD | +2,070,172 | +350.0% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ken Griffin | ADD | +470,826 | +390.0% |
| Jim Simons | REDUCE | -186,400 | -89.5% |
Who Owns RARE? Superinvestor Holdings
ULTRAGENYX PHARMACEUTICAL IN is held by 2 tracked superinvestors, with a combined position value of $70 million . The largest positions are held by Ken Griffin (0.0% of portfolio), Jim Simons (0.0% of portfolio).
In the most recent quarter, 2 superinvestors added or initiated positions.